Hyperphosphatemia
Also known as: Hyperphosphataemia / Hyperphosphatemia (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11081 | Aluminum chloride | Indicated for the control of minor hemorrhage during dental restorative procedures. Indicated to reduce underarm perspiration. |
| DB06723 | Aluminum hydroxide | An antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach. |
| DB00258 | Calcium acetate | A phosphate binder used in patients with end-stage renal disease (ESRD) to prevent elevated phosphate levels and resulting ectopic calcification and secondary hyperparathyroidism. |
| DB06724 | Calcium carbonate | An ionic compound used as a calcium supplement or antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach. |
| DB11634 | Colestilan chloride | Colestilan is an ingredient in the EMA-withdrawn product BindRen. |
| DB13949 | Ferric cation | An iron supplement indicated in the treatment of iron deficiency anemia. |
| DB09146 | Iron sucrose | An compound used as a source of iron in patients with iron deficiency anemia associated with chronic kidney disease (CKD). |
| DB06792 | Lanthanum carbonate | A phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease. |
| DB00658 | Sevelamer | A phosphate binder used to treat hyperphosphatemia. |
| DB14520 | Tetraferric tricitrate decahydrate | A phosphate binder used to control serum phosphorus levels or as an iron supplement. |